SOMERSET, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) ("CareCloud" or the "Company"), a leader in AI-driven healthcare technology solutions for medical practices and health systems nationwide, today announced that it has been added to the Russell Microcap® Index, effective at the open of U.S. markets on June 30, 2025, as part of the Russell indexes' annual reconstitution based on market capitalization, public float, and related criteria. The inclusion underscores growing re ...

SOMERSET, N.J., July 01, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) ("CareCloud" or the "Company"), a leader in AI-driven healthcare technology solutions for medical practices and health systems nationwide, today announced that it has surpassed the accelerated filer threshold with a public float of $85.1 million as of the market close on June 30, 2025. This achievement triggers a new compliance benchmark under SEC regulations—specifically, the inclusion of an auditor attestation of the C ...

CARMEL, Ind., May 27, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that the Indiana Department of Administration in collaboration with the Family and Social Services Administration/Division of Mental Health and Addiction has recommended Syra Health for contract negotiations to implement Indiana's Child Mental Health Wraparound Acce ...

NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Veri Medtech Holdings, Inc. (Stock Ticker Symbol: “VRHI”) ("Veri Medtech"), healthcare technology platform, announced today that $3,308,297 in revenue was generated during the first quarter of 2025, with an aggregate of up to $100 million in sales revenue generated since inception in 2017. For more information, please visit: www.VeriMedtech.com Additional Key Accomplishments: Retained PCAOB Auditor (in preparation for uplisting)Announced up to 400,000 Patients Mile ...

Revenue increase led by Population Health's 261% YoY ExpansionGross Margin Improves Substantially to 31.7%, up 14.6 Percentage Points YoYContinued Efficiency Gains Cut Q1 2025 Net Losses by Over Two Thirds Compared to Q1 2024A conference call will be held today, Thursday, May 8, at 9:00 am ETCARMEL, Ind., May 8, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and ...

文章核心观点 - 威睿医疗科技（Veri Medtech）重新推出其Veriheal.com医疗技术平台 [1] 公司动态 - 公司重新推出Veriheal.com医疗技术平台 [1] - 升级后的Veriheal.com平台将巩固其在服务市场的领先地位 [2] 公司概况 - Veriheal是威睿医疗科技旗下子公司，致力于帮助人们获得药物 [3] - 威睿医疗科技是一家上市医疗技术公司，提供替代药物、个性化诊断和健康药物按需服务 [3] - 公司利用远程医疗基础设施、诊断智能和可扩展数字系统满足医疗需求 [3] - 公司积极探索收购以增强核心能力，提高患者参与度 [3] - 公司通过生成高价值患者数据库和重复服务模式推动收入增长 [3] - 公司致力于创新和以患者为中心的护理，扩大服务范围和影响力 [3]

公司动态 - Acentra Health获得加州医疗保健服务部(DHCS)为期两年2750万美元的合同 包含一年可选延期 继续为加州长期护理机构的PASRR项目提供一级初步筛查和二级评估服务[1] - 新合同通过竞争性采购流程授予 延续公司自2015年以来作为加州医疗补助计划PASRR服务供应商的合作关系[2] - 公司近期还新增堪萨斯州和华盛顿州的PASRR二级评估服务 业务版图扩展至8个州 其中堪萨斯项目2025年4月1日生效 华盛顿项目2024年7月1日生效[5] 业务规模 - 加州拥有全美最大的PASRR项目 Acentra Health每年为该州执行约233万次一级筛查和18万次二级评估[4] - 公司在PASRR领域拥有23年全国服务经验 30年医疗补助受益者医疗需求评估经验[4][6] 技术能力 - 与加州合作期间 公司通过优化临床工作流程将PASRR平均处理时间缩短至不足2天 远低于联邦基准[4] - PASRR服务包含一级筛查 二级评估 判定通知处理 全套IT系统支持 以及每日/月度报告体系[6] 行业背景 - PASRR是联邦强制筛查程序 用于识别医疗补助认证长期护理机构申请者是否患有严重精神疾病 智力障碍或发育障碍 确保患者在限制最少的环境中获得服务[3] - 公司通过临床有效的评估建议 在保障个人权益的同时确保各州符合联邦合规要求[6] 公司概况 - Acentra Health结合公共部门经验 临床专业知识和技术创新 为政府及商业客户提供医疗解决方案 业务涵盖理赔管理 临床评估 质量监督等领域[7] - 公司由全球投资机构凯雷集团(NASDAQ: CG)支持[7]

NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Veri Medtech Holdings, Inc. (OTC Markets: (“VRHI”) ("Veri Medtech") announced today that it has retained Salberg & Company, P.A., as its PCAOB auditor, in furtherance of the uplisting process. For more information, please visit: http://www.salbergco.com. "Veri Medtech (VRHI) continues to execute on its mission to be the premier provider of healthcare technology services and products worldwide. Retaining Salberg & Company is an important strategic next step in the ...